New research indicates that patients who discontinue blockbuster slimming jabs like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who stop traditional diet and exercise programs.
Research printed in a major health publication demonstrates that while overweight people frequently drop a large proportion of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month once they quit.
"Individuals buying these treatments should be aware of the risk of fast weight regain when the therapy concludes," warns researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment mass within about 18 months.
Weighing Approaches
The analysis, which examined dozens of trials involving thousands of participants, contrasted the results of these new drugs with other pills.
The team emphasize that individuals who shed pounds through diet and exercise usually see a more gradual creep back—approximately 0.1 kg a month—once they finish.
Explaining the Fast Regain
Experts suggest the mechanism of the injections is key to understanding the amplified weight return.
GLP-1 drugs mimic a body's own chemical called GLP-1, which moderates hunger.
"Long-term administration of GLP-1 levels several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this hormone supplement leads to hunger is unsuppressed, making overeating a significant risk."
An Ongoing Disease?
Medical guidelines recommend the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
Professionals say that, given the significant potential of relapse, the therapy might need to be long-term.
This perspective is echoed by drug manufacturers, who state that the findings "emphasize the long-term character of obesity," similar to managing diseases like diabetes.
Patient Experiences
Individuals who have come off the jabs explain a powerful resurgence of cravings.
"It felt as if a switch flipping and I was suddenly starving," said one woman.
This difficulty is worsened if patients have not established permanent lifestyle or habit changes during therapy.
Significant Use
Survey data suggest that a significant number of people in the UK have tried these injections in the past year, with interest being substantial.
- Adoption is more common among females compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the medications through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic fix and maintained weight loss likely depends on ongoing lifestyle changes.
